Filter posts

ICYMI: Reagan-Udall Foundation Launches Expanded Access Navigator for Patients and Physicians

The Reagan-Udall Foundation for the Food and Drug Administration (FDA) recently announced the release of …

Taking on High-Risk Investments to Understand Brains and Solve Epilepsy

30 percent of people living with epilepsy do not have seizure control. Moreover, many can …

Principles on Clinical Trial Data Sharing Reaffirm Commitment

BIO member companies will honor, at minimum, the following commitments: REGISTERING CLINICAL TRIALS: BIO member …

Successful Public-Private Partnerships

According to BayBio, biomedical companies that can harness the power of patient groups will get …

Uniting To Accelerate Pediatric Medicine

Drug companies inherently absorb significant risk when developing compounds and biologics for clinical use. A …

New FDA Final Guidance on Clinical Trial Institutional Review Boards

On Tuesday, August 27th, the FDA finalized its Guidance for Institutional Review Boards, Clinical Investigators …

FDA Issues Final Guidance on Clinical Trial Oversight

The FDA released its final guidance governing clinical trial oversight and urges a risk-based approach …

Research: Working Together Toward Cures

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require …

Learning the Truth About Clinical Trials

There are currently over 60,000 clinical trials occurring in the United States. These programs not …

Fox Trial Finder and You: Use It to Recruit for Your Trials or to Get Involved Yourself!

From The Michael J. Fox Foundation for Parkinson’s Research The Michael J. Fox Foundation has launched …